CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 10.80 -0.45 (-4.00%) As of 07:53 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 8.00%. In the past month, the stock has decreased 56.45%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 10.75 with a market cap of £1.17 million and volume of 15,725 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.46%1 Month Performance-56.45%3 Month Performance+8.00%Year-To-Date Performance+8.00% CRTX Stock Chart for Tuesday, July, 15, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/14/2025GBX 11.67GBX 10.75-7.88%GBX 11.65GBX 10.7515,725 shs£1.17 million07/11/2025GBX 11.67GBX 11.67GBX 12GBX 10.7560,950 shs£1.27 million07/10/2025GBX 11.67GBX 11.67GBX 11.67GBX 11.25214 shs£1.27 million07/09/2025GBX 10.75GBX 11.67+8.56%GBX 12GBX 11.2536,572 shs£1.27 million07/08/2025GBX 10.50GBX 10.75+2.38%GBX 11.70GBX 10.755,902 shs£1.17 million07/07/2025GBX 11GBX 10.50-4.55%GBX 11.20GBX 10933,000 shs£1.14 million07/04/2025GBX 11.29GBX 11.29GBX 11.50GBX 10.7082,879 shs£1.23 million07/03/2025GBX 11.40GBX 11.29-0.96%GBX 11.50GBX 10.7082,879 shs£1.23 million07/02/2025GBX 11.38GBX 11.40+0.21%GBX 11.50GBX 11.40286,869 shs£1.24 million07/01/2025GBX 11.80GBX 11.38-3.60%GBX 12GBX 11.38189,663 shs£1.24 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/30/2025GBX 19.15GBX 11.80-38.38%GBX 16GBX 11870,783 shs£1.29 million06/27/2025GBX 23GBX 19.15-16.74%GBX 23GBX 1928,912 shs£2.09 million06/26/2025GBX 20GBX 23+15.00%GBX 23GBX 2011,881 shs£2.51 million06/25/2025GBX 20.10GBX 20-0.50%GBX 21.50GBX 2054,184 shs£2.18 million06/24/2025GBX 22GBX 20.10-8.64%GBX 25GBX 20.1048,061 shs£2.19 million06/23/2025GBX 22GBX 22GBX 25GBX 224,278 shs£2.40 million06/20/2025GBX 23.50GBX 22-6.38%GBX 23.50GBX 229,976 shs£2.40 million06/19/2025GBX 23.60GBX 23.50-0.42%GBX 25GBX 2225,670 shs£2.56 million06/18/2025GBX 22.10GBX 23.60+6.79%GBX 23.60GBX 22.103,580 shs£2.57 million06/17/2025GBX 23GBX 22.10-3.91%GBX 25GBX 2280,758 shs£2.41 million06/16/2025GBX 24.80GBX 23-7.26%GBX 25GBX 23461,201 shs£2.51 million Related Companies Firering Strategic Minerals Stock Price Chart Bradda Head Lithium Stock Price Chart Cadence Minerals Stock Price Chart GreenRoc Mining Stock Price Chart Aterian Stock Price Chart Anglesey Mining Stock Price Chart Beowulf Mining Stock Price Chart Jangada Mines Stock Price Chart PYX Resources Stock Price Chart Altona Rare Earths Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.